1What is chronic obstructive pulmonary disease (COPD)? World Health Organisation.2013.
http://www.who.int/features/qa/48/en/ (accessed August 2018)
Spiolto® Respimat® is a once daily long-acting LAMA/LABA therapy of tiotropium 5 mcg (LAMA) and olodaterol 5 mcg (LABA), delivered via Respimat®. It is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Spiolto® Respimat® is administered as 2 puffs, once daily.1
1. Spiolto® Prescribing Information
Production date: Mar 2019